Back to search

Article

CD248(TEM1/CD164L1/Endosialin): A new molecular target for anti-angiogenic therapy in Pancreatic ductal adenocarcinoma

2021-03-18

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Pancreatic ductal adenocarcinoma (PDCA) is one of the malignant tumors with the worst prognosis with a 5-year survival rate of <1%, which is known as the "king of cancers". At present, there is a lack of effective early diagnosis and treatment plan for pancreatic cancer. Therefore, there is an urgent need to understand the molecular mechanisms of pancreatic canc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
62ed9171-ae83-5cf1-96bf-bfbfd0ca1d46
DOI
10.21203/rs.3.rs-217476/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CD248(TEM1/CD164L1/Endosialin): A new molecular target for anti-angiogenic therapy in Pancreatic ductal adenocarcinomaDOI 10.21203/rs.3.rs-217476/v1
Select a neighboring publication to make it the new centre.